Today at Berkeley Lab

Toward a Blueprint for Anti-influenza Drugs

Vaccines can reduce the number of flu infections, but antiviral drugs are still needed for treatment once infections occur. In recent years, resistance to some anti-influenza drugs has become a problem. At the Advanced Light Source, researchers learned how several such drugs disrupt replication of the flu virus. The studies provide atomic-level blueprints from which to design drugs that can overcome growing drug resistance. More>